of the management in order to assist investors to better understand the company's financial status and operation. It also supports the "Good Corporate Governance Project" of the Securities and Exchange

2Q18 as gain from fair value adjustment of investment property. Page 7 of 7 Management Discussion and Analysis 2Q2019 Financial Position and Capital Structure As at 30 June 2019, the Company reported

, Bangkok 10330 Tel. 66 2 654 3344 Fax. 66 2 654 3323 Financial Summary Statement of Financial Performance Revenues For Q3 2017 fiscal year ended 30 September 2017, the Company had total revenues of 2,132

10330 Tel. 66 2 654 3344 Fax. 66 2 654 3323 Financial Summary Statement of Financial Performance Revenues For Q3 2017 fiscal year ended 30 September 2017, the Company had total revenues of 2,132 Million

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

Microsoft Word - à¸−ี๛ๆซà¸⁄ผลฆารà¸flำ๕ฎิฎà¸⁄าฎ GELQ32561-EN Page 1 of 4 GEL.CS.025/2561 13 November 2018 Subject Management Discussion and Financial Analysis for the

sales of goods 68.69 78.40 88.84 74.81 20.15 29.33 Gross profit 18.92 21.60 29.91 25.19 10.99 58.09 Other income 1.07 1.22 0.51 0.43 (0.56) (52.34) Gain on exchange rate 0.22 0.25 0.13 0.11 (0.09) (40.91

MDA_EN_4Q22 Management Discussion and Analysis Fiscal year ended February 28, 2023 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the audited financial

Million for Last Year Quarter mainly due to increase in loss on devaluation of Finished Goods and Raw Material by THB 158 Million and lower Foreign Exchange Gain by THB 95 Million compared to Last Year

& Trading Business Group 11 Marketing Business Group 13 Power Plant Business Group 14 Bio-Based Products Business Group 16 Natural Resources Business Group 18 Statement of Financial Position 20 Cash Flows